This presentation will review new vaccines available in the U.S. market and newer formulations of previously available vaccines. A discussion on the pros and cons of their administration and their place in the primary care provider’s practice will help clinicians more effectively manage vaccines for their patients.
Human papillomavirus (HPV) is the most common sexually transmitted infection. In addition to causing cervical cancers, HPV is responsible for 90% of anal cancers and 70% of oropharyngeal cancers, and affects both men and women. This activity provides an update on the prevention of HPV-related cancers and the newly expanded vaccine indications.